Revolution Medicines retained earnings (accumulated deficit) for the quarter ending September 30, 2024 were $-1.543B, a 58.09% increase year-over-year.
Revolution Medicines retained earnings (accumulated deficit) for 2023 were $-1.138B, a 62.22% increase from 2022.
Revolution Medicines retained earnings (accumulated deficit) for 2022 were $-0.701B, a 54.95% increase from 2021.
Revolution Medicines retained earnings (accumulated deficit) for 2021 were $-0.453B, a 70.46% increase from 2020.